Clinical measurement ontology
3992 terms(s) returned
| Term Type: Class | Record: 2701 to 2750 of 3992 Records | Page: 55 of 80, First Previous Next Last | Show Records Per Page |
- percentage of study population developing ventral prostate tumorous lesions during a period of time
- percentage of study population developing ventral prostate tumorous lesions with a solid structure during a period of time
- percentage of study population developing ventral prostate tumorous lesions with round, irregular size nuclei during a period of time
- percentage of study population developing well differentiated malignant colorectal tumors during a period of time
- percentage of study population displaying T-cell lymphomas at a point in time
- percentage of study population displaying Toxoplasma gondii brain cysts at a point in time
- percentage of study population displaying acute experimental autoimmune encephalomyelitis at a point in time
- percentage of study population displaying anorectal malformation at a point in time
- percentage of study population displaying benign colorectal tumors at a point in time
- percentage of study population displaying benign liver tumors at a point in time
- percentage of study population displaying bilateral renal agenesis at a point in time
- percentage of study population displaying bilateral testis tumors at a point in time
- percentage of study population displaying cataract at a point in time
- percentage of study population displaying cerebrovascular lesions at a point in time
- percentage of study population displaying chronic experimental arthritis at a point in time
- percentage of study population displaying chronic experimental autoimmune encephalomyelitis at a point in time
- percentage of study population displaying chronic pancreatitis at a point in time
- percentage of study population displaying colonic aganglionosis at a point in time
- percentage of study population displaying colorectal tumors at a point in time
- percentage of study population displaying diabetes mellitus at a point in time
- percentage of study population displaying endometrial adenocarcinomas at a point in time
- percentage of study population displaying endometrioid carcinoma at a point in time
- percentage of study population displaying experimental arthritis at a point in time
- percentage of study population displaying experimental autoimmune encephalomyelitis at a point in time
- percentage of study population displaying experimental autoimmune neuritis at a point in time
- percentage of study population displaying experimental diabetes mellitus at a point in time
- percentage of study population displaying glycosuria at a point in time
- percentage of study population displaying hematuria at a point in time
- percentage of study population displaying hepatocellular carcinoma at a point in time
- percentage of study population displaying herpes simplex encephalitis at a point in time
- percentage of study population displaying intestine tumors at a point in time
- percentage of study population displaying kidney edema at a point in time
- percentage of study population displaying kidney tubular degeneration at a point in time
- percentage of study population displaying leukemia at a point in time
- percentage of study population displaying liver edema at a point in time
- percentage of study population displaying liver hyperemia at a point in time
- percentage of study population displaying liver parenchymal degeneration at a point in time
- percentage of study population displaying liver tumors at a point in time
- percentage of study population displaying lung tumors at a point in time
- percentage of study population displaying malignant colorectal tumors at a point in time
- percentage of study population displaying malignant liver tumors at a point in time
- percentage of study population displaying mammary tumors at a point in time
- percentage of study population displaying metastatic liver tumors at a point in time
- percentage of study population displaying metastatic tumors in the lung at a point in time
- percentage of study population displaying myeloid leukemia at a point in time
- percentage of study population displaying pituitary gland hyperplastic lesions at a point in time
- percentage of study population displaying pituitary tumors at a point in time
- percentage of study population displaying poorly differentiated malignant colorectal tumors at a point in time
- percentage of study population displaying prostate tumorous lesions at a point in time
- percentage of study population displaying prostate tumors at a point in time
